後續研究以及未來展望

第五章結論與建議

第四節後續研究以及未來展望

一、心房顫動警示系統正式上線的後續研究

此試驗為心房顫動警示系統正式上線前的前導研究，在蒐集使用者意見以及

模型推導之後，作為之後正式上線的調整與參考。在調整後正式上線，可以進一步驗證此警示系統是否能增加使用者開立抗凝血劑之比例，或是進一步影響患者之中風或生存預後。亦可進一步分析使用者對於警示系統的反應時間或是反應動作和其背景特徵或是使用環境之關聯。正式上線後，亦可擴大受測者範圍，包括使用相同資訊系統的不同院區，或是不同資訊系統，類似的警示系統設計研究。

二、警示系統科技接受模型和題項之後續研究

對於本研究發展之警示系統科技接受模型，可用不同的疾病和其警示系統來進一步驗證。可發展不同疾病的知識量表，以此警示系統科技接受模型進一步驗證，或是找尋其他的前置變項，例如患者的背景資料、疾病嚴重程度、家屬因素…

等。另一方面，亦可進一步研究主觀規範除了可直接影響使用意願之外，是否亦可影響認知有用性(Kim & Park, 2012)。

三、Jessa 心房顫動知識問卷的後續研究

此 Jessa 心房顫動知識問卷為華文世界第一份經過正式授權，雙向翻譯，官方認可之中文化心房顫動知識評量問卷。可先於一般無就診心臟科民眾、一般就診心臟科，無心房顫動患者、就診心臟科且有心房顫動的患者，做信效度和區辨度測驗。並且可以用前／後測的方式來做為後續心房顫動衛教、不同科別治療、

藥物和非藥物治療心房顫動之患者心房顫動知識增長評量。或是評量不同的衛教方式、不同的衛教媒介、或是不同的介入方式，來評量心房顫動患者其心房顫動知識的變化，甚至預後的改善。

參考文獻

中文部分

王嵩竑。(2008)。護理人員對無線射頻辨識系統接受度模式建構與比較分析：知覺創新特性模式與科技接受模式觀點。元培學報，(15)，頁 47-80。

石崇良、蘇喜。(2004)。運用資訊提升病人安全。臺灣醫學，8(6)，807-816。

吳曉雲、邱艷芬。(2011)。心臟衰竭患者的疾病知識與自我照顧行為。護理暨健康照護研究，7(4)，頁 329-338。

李作英、王如華、徐姍姍、陳麗芳、張雪吟。(1998)。護理資訊化-個人數位處理器(PDA)在臨床護理之運用。護理雜誌，45(1)，頁 69-76。

李婉怡、趙珮如。(2004)。醫療產業員工對電子病歷之科技接受模式探討-以中南部地區為例。醫務管理期刊，5(2)，頁 243-269。

李榮信。(2010)。以計劃行為理論探討醫療服務人員知識分享行為。成功大學高階管理碩士在職專班(EMBA)學位論文，頁 1-73。

李碧霞、呂昌明。(1995)。孕產婦授乳意圖，授乳行為及其影響因素之研究。護理研究，3(3)，頁 278-290。

周君倚、陸洛。(2014)。以科技接受模式探討數位學習系統使用態度-以成長需求為調節變項。資訊管理，21(1)，頁 83-106。

林盈利、陳清埤、余昭宏、林益卿。(2012)。心房顫動與抗血栓治療。家庭醫學與基層醫療，27(6)，頁 202-206。

林璟淑、李亭亭。(2005)。由 Lewin 的改變理論談護理資訊系統之推展。護理雜誌，52(1)，頁 50-54。

林璟淑、廖彥琦。(2003)。護理人員對運用個人數位助理(PDA)於護理作業之態度與滿意度調查。新臺北護理期刊，5(2)，頁 3-12。

洪新原、梁定澎、張嘉銘。(2005)。科技接受模式之彙總研究。資訊管理學報，

12(4)，頁 211-234。

張怡秋、劉忠峰、蕭世榮、陳瑩玲。(2005)。護理站導入無線區域網路之關鍵因素研究。資訊管理學報，12(4)，頁 107-119。

張顯洋。(2001)。個人數位秘書 PDA 在臨床護理工作的應用—以慈濟醫學中心護囑資訊系統之整合研究為例。Hospital，34(1)，頁 8-15。

陳朝欽、雷孟桓。(2012)。新型口服抗凝血劑─心房顫動中風預防的新曙光。內科學誌，23(2)，頁 77-97。

陳福基、蕭世榮、陳啟元、杜素珍。(2005)。影響醫院接受行動護理站因素之研究-以南部某區域教學醫院為例。資訊管理學報，12(S)，頁 67-89。

曾旭民、詹碧端、姜靜穎。(2009)。應用科技接受模型探討護理人員對行動護理站接受度的影響因素。醫療資訊雜誌，18(1)，頁 23-38。

曾志仁、邱政元、蔡亭儀、梁竣傑、許瑋庭。(2012)。使用電子病歷保障病人隱私之探討—以中山醫學大學附設醫院病歷電子化為例。電腦稽核(25)，頁 112-119。

劉家昌、林益卿、黃馨葆。(2017)。新型口服抗凝血藥物在預防心房纖維顫動患者中風預防的使用。家庭醫學與基層醫療，32(11)，頁 314-321。

蔡昆原、劉見祥、劉建財。(2009)。我國電子病歷發展現況與展望。醫療品質雜誌，3(6)，頁 4-14。

梁定澎。(2012) 。資訊管理理論。前程文化出版總經銷。新北市。

鄧景宜、賀倫惠、陳瑋佳。(2009)。健康專業服務的改善:應用理性行為理論解釋護理人員通報病患安全事件意願的影響因素。管理評論，28(1)，頁 45-60。

英文部分

Ahlan, A. R., & Ahmad, B. I. e. (2015). An overview of patient acceptance of Health Information Technology in developing countries: a review and conceptual model.

International Journal of Information Systems and Project Management, 3(1), 29-48.

Ajzen, I. (2006). Constructing a theory of planned behavior questionnaire. In: Amherst, MA.

Ajzen, I., & Fishbein, M. (1975). A Bayesian analysis of attribution processes.

Psychological Bulletin, 82(2), 261.

Ajzen, I., & Fishbein, M. (1980). Understanding attitudes and predicting social behaviour.

Ajzen, I., & Fishbein, M. (1988). Theory of reasoned action-Theory of planned behavior. University of South Florida.

Arnould, E., Price, L., & Zinkhan, G. (2004). Consumers. McGraw-‐Hill. Irwin, New York.

Barclay, D., Higgins, C., & Thompson, R. (1995). The Partial Least Squares (pls) Approach to Casual Modeling: Personal Computer Adoption Ans Use as an Illustration.

Bates, D. W., & Gawande, A. A. (2003). Improving safety with information technology.

New England Journal of Medicine, 348(25), 2526-2534.

Bates, D. W., Leape, L. L., Cullen, D. J., Laird, N., Petersen, L. A., Teich, J. M., . . . Shea, B. (1998). Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA, 280(15), 1311-1316.

Bates, D. W., Miller, E. B., Cullen, D. J., Burdick, L., Williams, L., Laird, N., . . . Vander Vliet, M. (1999). Patient risk factors for adverse drug events in hospitalized patients. Archives of Internal Medicine, 159(21), 2553-2560.

Bates, D. W., Teich, J. M., Lee, J., Seger, D., Kuperman, G. J., Ma'Luf, N., . . . Leape, L. (1999). The impact of computerized physician order entry on medication error prevention. Journal of the American Medical Informatics Association, 6(4), 313-321.

Becker, T. E., Randall, D. M., & Riegel, C. D. (1995). The multidimensional view of commitment and the theory of reasoned action: A comparative evaluation. Journal of Management, 21(4), 617-638.

Bollen, K. A., & Stine, R. A. (1992). Bootstrapping goodness-of-fit measures in structural equation models. Sociological Methods & Research, 21(2), 205-229.

Bostrom, R. P., & Heinen, J. S. (1977). MIS problems and failures: a socio-technical perspective, part II: the application of socio-technical theory. MIS quarterly, 11-28.

Camm, A. J., Breithardt, G., Crijns, H., Dorian, P., Kowey, P., Le Heuzey, J.-Y., . . . Schwartz, P. J. (2011). Real-life observations of clinical outcomes with rhythm-and rate-control therapies for atrial fibrillation: RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). Journal of the American College of Cardiology, 58(5), 493-501.

Chien, K.-L., Su, T.-C., Hsu, H.-C., Chang, W.-T., Chen, P.-C., Chen, M.-F., & Lee, Y.-T. (2010). Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese. International Journal of Cardiology, 139(2), 173-180.

Chin, W. W. (1998). The partial least squares approach to structural equation modeling.

Modern methods for business research, 295(2), 295-336.

Choi, J., Chun, J., Lee, K., Lee, S., Shin, D., Hyun, S., . . . Kim, D. (2004). MobileNurse:

hand-held information system for point of nursing care. Computer Methods and Programs in Biomedicine, 74(3), 245-254.

Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., . . . Varrone, J. (2009). Dabigatran versus warfarin in patients with atrial fibrillation.

New England Journal of Medicine, 361(12), 1139-1151.

Davis, F. D. (1985). A technology acceptance model for empirically testing new end-user information systems: Theory and results. Massachusetts Institute of Technology,

Davis, F. D. (1989). Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS quarterly, 319-340.

Davis, F. D., Bagozzi, R. P., & Warshaw, P. R. (1989). User acceptance of computer technology: a comparison of two theoretical models. Management science, 35(8), 982-1003.

Davis, F. D., Bagozzi, R. P., & Warshaw, P. R. (1992). Extrinsic and intrinsic motivation to use computers in the workplace. Journal of Applied Social Psychology, 22(14), 1111-1132.

Dessau, R. B., & Steenberg, P. (1993). Computerized surveillance in clinical microbiology with time series analysis. Journal of Clinical Microbiology, 31(4), 857-860.

Desteghe, L., Engelhard, L., Raymaekers, Z., Kluts, K., Vijgen, J., Dilling-Boer, D., . . . Heidbuchel, H. (2016). Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire. Int J Cardiol, 223, 906-914.

doi:10.1016/j.ijcard.2016.08.303

Erickson, S. M., Wolcott, J., Corrigan, J. M., & Aspden, P. (2003). Patient safety:

achieving a new standard for care: National Academies Press.

Evans, R. S., Pestotnik, S. L., Classen, D. C., Clemmer, T. P., Weaver, L. K., Orme Jr, J. F., . . . Burke, J. P. (1998). A computer-assisted management program for antibiotics and other antiinfective agents. New England Journal of Medicine, 338(4), 232-238.

Fishbein, M., & Ajzen, I. (1977). Belief, attitude, intention, and behavior: An introduction to theory and research.

Fiszman, M., Chapman, W. W., Aronsky, D., Evans, R. S., & Haug, P. J. (2000).

Automatic detection of acute bacterial pneumonia from chest X-ray reports.

Journal of the American Medical Informatics Association, 7(6), 593-604.

Fornell, C., & Larcker, D. F. (1981). Evaluating structural equation models with unobservable variables and measurement error. Journal of marketing research, 39-50.

Granger, C. B., Alexander, J. H., McMurray, J. J., Lopes, R. D., Hylek, E. M., Hanna, M., . . . Avezum, A. (2011). Apixaban versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 365(11), 981-992.

Hair, J. F., Black, W. C., Babin, B. J., Anderson, R. E., & Tatham, R. L. (1998).

Multivariate data analysis . Uppersaddle River. Multivariate Data Analysis (5th ed) Upper Saddle River.

Hirschhorn, L. R., Currier, J. S., & Platt, R. (1993). Electronic surveillance of antibiotic exposure and coded discharge diagnoses as indicators of postoperative infection and other quality assurance measures. Infection Control and Hospital Epidemiology, 14(1), 21-28.

Hripcsak, G., Friedman, C., Alderson, P. O., DuMouchel, W., Johnson, S. B., &

Clayton, P. D. (1995). Unlocking clinical data from narrative reports: a study of natural language processing. Annals of Internal Medicine, 122(9), 681-688.

Hu, P. J., Chau, P. Y., Sheng, O. R. L., & Tam, K. Y. (1999). Examining the technology acceptance model using physician acceptance of telemedicine technology. Journal of management information systems, 16(2), 91-112.

Investigation, A. F. (1994). Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooted data from five randominized controlled trials: J. Archives of Internal Medicine, 154(13), 1449-1414.

Jha, A. K., Kuperman, G. J., Rittenberg, E., Teich, J. M., & Bates, D. W. (2001).

Identifying hospital admissions due to adverse drug events using a computer‐

based monitor. Pharmacoepidemiology and Drug Safety, 10(2), 113-119.

Kaushal, R., Shojania, K. G., & Bates, D. W. (2003). Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Archives of Internal Medicine, 163(12), 1409-1416.

Kim, J., & Park, H. A. (2012). Development of a health information technology acceptance model using consumers' health behavior intention. J Med Internet Res, 14(5), e133. doi:10.2196/jmir.2143

Lane, D. A., Ponsford, J., Shelley, A., Sirpal, A., & Lip, G. Y. (2006). Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme: the West Birmingham Atrial Fibrillation Project. International Journal of Cardiology, 110(3), 354-358.

Lee, C.-H., Liu, P.-Y., Tsai, L.-M., Tsai, W.-C., Ho, M.-T., Chen, J.-H., & Lin, L.-J.

(2007). Characteristics of hospitalized patients with atrial fibrillation in Taiwan: a

nationwide observation. The American journal of medicine, 120(9), 819. e811-819. e817.

Lierman, L. M., Young, H. M., Kasprzyk, D., & Benoliel, J. Q. (1990). Predicting breast self-examination using the theory of reasoned action. Nursing Research, 39(2), 97-102.

Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest Journal, 137(2), 263-272.

McCabe, P. J., Schad, S., Hampton, A., & Holland, D. E. (2008). Knowledge and self-management behaviors of patients with recently detected atrial fibrillation. Heart Lung, 37(2), 79-90. doi:10.1016/j.hrtlng.2007.02.006

Miller, M. R., Elixhauser, A., Zhan, C., & Meyer, G. S. (2001). Patient Safety Indicators:

using administrative data to identify potential patient safety concerns. Health Services Research, 36(6 Pt 2), 110.

Nunnally, J. (1978). Psychometric theory (2nd edit.) mcgraw-hill. Hillsdale, NJ.

Obamiro, K. O., Chalmers, L., & Bereznicki, L. R. (2016). Development and Validation of an Oral Anticoagulation Knowledge Tool (AKT). PLoS One, 11(6), e0158071.

doi:10.1371/journal.pone.0158071

Ohsawa, M., Okayama, A., Okamura, T., Itai, K., Nakamura, M., Tanno, K., . . . Sakata, K. (2007). Mortality risk attributable to atrial fibrillation in middle-aged and elderly people in the Japanese general population. Circulation Journal, 71(6), 814-819.

Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., . . . Piccini, J. P. (2011). Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New England Journal of Medicine, 365(10), 883-891.

Rolls, C. A., Obamiro, K. O., Chalmers, L., & Bereznicki, L. R. (2017). The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation.

Cardiovascular Therapeutics, 35(6).

Rozich, J., Haraden, C., & Resar, R. (2003). Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Quality and safety in Health Care, 12(3), 194-200.

Scarpa, R., Smeltzer, S. C., & Jasion, B. (1992). Attitudes of nurses toward computerization: a replication. In.

Schumock, G., Thornton, J., & Witte, K. (1991). Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions. American Journal of Hospital Pharmacy, 48(9), 1974-1976.

Shih, Y.-Y., & Fang, K. (2004). The use of a decomposed theory of planned behavior to study Internet banking in Taiwan. Internet research, 14(3), 213-223.

Short, D., Frischer, M., & Bashford, J. (2004). Barriers to the adoption of computerised decision support systems in general practice consultations: a qualitative study of GPs’ perspectives. International Journal of Medical Informatics, 73(4), 357-362.

Singer, D. E., Chang, Y., Fang, M. C., Borowsky, L. H., Pomernacki, N. K., Udaltsova, N., & Go, A. S. (2009). Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?

Circulation: Cardiovascular Quality and Outcomes, 2(4), 297-304.

Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., . . . Group, E. S. C. S. D. (2018). The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. EP Europace, euy054-euy054.

doi:10.1093/europace/euy054

Straub, D., Boudreau, M.-C., & Gefen, D. (2004). Validation guidelines for IS positivist research. Communications of the Association for Information systems, 13(1), 24.

Szajna, B. (1996). Empirical evaluation of the revised technology acceptance model.

Management science, 42(1), 85-92.

Tanizaki, Y., Kiyohara, Y., Kato, I., Iwamoto, H., Nakayama, K., Shinohara, N., . . . Fujishima, M. (2000). Incidence and risk factors for subtypes of cerebral infarction in a general population. Stroke, 31(11), 2616-2622.

Teich, J. M., Merchia, P. R., Schmiz, J. L., Kuperman, G. J., Spurr, C. D., & Bates, D.

W. (2000). Effects of computerized physician order entry on prescribing practices.

Archives of Internal Medicine, 160(18), 2741-2747.

van Walraven, C., Hart, R. G., Singer, D. E., Laupacis, A., Connolly, S., Petersen, P., . . . Hellemons, B. (2002). Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA, 288(19), 2441-2448.

Venkatesh, V., & Davis, F. D. (2000). A theoretical extension of the technology acceptance model: Four longitudinal field studies. Management science, 46(2), 186-204.

Waegemann, C. (1999). Current Status of EPR Developments in the US. Toward an electronic health record, 99, 116-118.

Wilson, E. V., & Lankton, N. K. (2004). Modeling patients' acceptance of provider-delivered e-health. Journal of the American Medical Informatics Association, 11(4), 241-248.

Wu, J.-H., Wang, S.-C., & Lin, L.-M. (2007). Mobile computing acceptance factors in the healthcare industry: A structural equation model. International Journal of Medical Informatics, 76(1), 66-77.

Yap, K. B., Ng, T. P., & Ong, H. Y. (2008). Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: a population-based study. Journal of Electrocardiology, 41(2), 94-98.

Zhou, Z., & Hu, D. (2008). An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. Journal of Epidemiology, 18(5), 209-216.

附錄研究問卷

醫學知識差異影響心房顫動警示系統之科技接受模型問卷—

院內專科護理師、藥師、醫師版

各位醫療同仁，您好！

衷心感謝，各位醫療同仁撥冗填寫這份問卷。本調查問卷目的在探討『醫學知識差異影響心房顫動警示系統之科技接受模型—以中文版 Jessa 心房顫動知識問卷為例』，問卷總共分為三個部分，採不記名方式作答，相關個人資料絕不對外公開，且問卷資料僅用於本次研究，本研究必定善盡保密之責，請放心依實際情形回答。

感謝您對研究協助與支持，敬祝您健康喜樂、工作順利。

國立台東大學資訊管理學研究所

研究生：邱威儒敬上

電子信箱：[email protected]

3. 以下消炎劑之一：例如阿司匹林(Aspirin)，布洛芬(Ibuprofen) 4. 我不知道

4. 關於新型血液稀釋劑（非維生素 K 拮抗劑口服抗凝血劑；新型口服抗凝血劑）

的問題

（）4.1 每天在同一時間服用血液稀釋劑是重要的。

1. 是 2. 不是

3. 不，只要是在兩餐之間就好 4. 我不知道

（）4.2 如果我忘記服用血液稀釋劑怎麼辦？

1. 我仍然應該服用這次劑量，除非到我的下一次劑量的時間少於我這次錯過劑量後的時間

2. 我應該跳過一個劑量，等到下次時間到再服用 3. 下次服藥時應服用兩粒

4. 我不知道

（）4.3 我的血液稀釋劑附有一張卡片（或是藥袋的說明）：

1. 讓我表明我服用血液稀釋劑

2. 我必須給我其他的診所醫生和次專科醫師看

在文檔中醫學知識差異影響心房顫動警示系統之科技接受模型—以中文版 (頁 86-105)

第五章 結論與建議

第四節 後續研究以及未來展望